Concepedia
Statistics
Publications
19
Citations
870
H-Index
17
Active since
2002
Affiliations
AstraZeneca (Canada)(Current)
Université de Montréal
Institut universitaire en santé mentale de Montréal
Université Laval
University of Ottawa
Alain Gendron is an author at AstraZeneca (Canada) specializing in quetiapine therapy, psychopharmacology, and psychiatry.
Publications per year
2002–2020
Quetiapine adjunct to selective serotonin reuptake inhibitors or venlafaxine in patients with major depression, comorbid anxiety, and residual depressive symptoms: a randomized, placebo-controlled pilot study
Alexander McIntyre, Alain Gendron, Amanda McIntyre · Depression and Anxiety · 2006 · 144 citations
Pharmacy, Pharmacotherapy, Psychiatry +15
Temporal effects of left versus right middle cerebral artery occlusion on spleen lymphocyte subsets and mitogenic response in Wistar rats
Alain Gendron, Jeanne Teitelbaum, Chantal Cossette et al. · Brain Research · 2002 · 85 citations
Life Sciences, Immunology, Physiology +11
Quetiapine augmentation of treatment-resistant depression: a comparison with lithium
Jean-Pierre Dorée, Joël Des Rosiers, Viviane Lew et al. · Current Medical Research and Opinion · 2007 · 83 citations
Pharmacy, Pharmacotherapy, Psychiatry +14
Quetiapine in patients with comorbid schizophrenia-spectrum and substance use disorders: an open-label trial
Stéphane Potvin, Émmanuel Stip, Olivier Lipp et al. · Current Medical Research and Opinion · 2006 · 68 citations
Medicine, Pharmacology, Psychiatry +17
Quetiapine as an adjunctive pharmacotherapy for the treatment of non-remitting generalized anxiety disorder: A flexible-dose, open-label pilot trial
Martin A. Katzman, Monica Vermani, Leslie Jacobs et al. · Journal of Anxiety Disorders · 2008 · 61 citations
Pharmacy, Pharmacotherapy, Psychiatry +13
1–5 of 19